Printer Friendly

ALTERNATIVE FORMS OF NITROGLYCERIN ARE AVAILABLE AS ANGINA PATIENTS FACE SHORTAGE OF SUBLINGUAL TABLETS

 COLLEGEVILLE, Pa., Jan. 11 /PRNewswire/ -- Recent news articles have reported a nationwide shortage of nitroglycerin sublingual tablets, but this should not represent a health hazard for angina patients since alternative forms of nitroglycerin are readily available.
 Rhone-Poulenc Rorer (NYSE: RPR) officials said news articles may have led people with angina to believe that an alternative source is not available if they run out of nitroglycerin tablets.
 The news articles have stated that the maker of sublingual nitroglycerin tablets is experiencing a temporary shortage and some pharmacies are out of the product.
 What news articles have not mentioned is that alternative forms of nitroglycerin, such as Nitrolingual(R) Spray (nitroglycerin lingual aerosol), are readily available to treat patients who need acute relief of an angina attack or prophylaxis of angina pectoris due to coronary artery disease.
 "The spray is an excellent alternative to tablets -- equally effective, easy to use, with no problems with loss of potency with Nitrolingual Spray," said Dr. Jonathan Abrams, professor of medicine, Cardiology, at the University of New Mexico School of Medicine, Albuquerque, N.M.
 Angina occurs when the muscular wall of the heart is deprived of oxygen for a short period of time due to narrowed heart arteries. It is experienced as a pain in the middle of the chest, but it may spread to the throat, and disappears when the activity stops. Properly treated, angina can be controlled quickly and effectively.
 "We encourage patients to ask their local pharmacist to contact their physicians to discuss alternative forms of nitroglycerin," said Lou Mitchell, P.D., member of the Executive Committee of the National Association of Retail Druggists.
 /delval/
 -0- 1/11/93
 /CONTACT: Bob Pearson of Rhone-Poulenc Rorer, 215-454-3872/
 (RPR)


CO: Rhone-Poulenc Rorer ST: Pennsylvania IN: MTC SU:

MP -- PH006 -- 3489 01/11/93 11:31 EST
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Jan 11, 1993
Words:301
Previous Article:READING COMPANY ISSUES ANNOUNCEMENT
Next Article:WYSE TECHNOLOGY: HEWLETT-PACKARD TO PROVIDE ON-SITE SERVICE FOR WYSE TECHNOLOGY PC AND UNIX-BASED SYSTEMS
Topics:


Related Articles
Nitroglycerin may relieve vision loss.
ASTRA TO MARKET NEW HEART DRUG
SANOFI WINTHROP AND RHONE-POULENC RORER INC. SIGN MARKETING, DISTRIBUTION AGREEMENT FOR ANTI-ANGINAL
NITROSTAT SUPPLIES REPLENISHED
NEW ONCE-A-DAY DRUG FOR ANGINA GAINS U.S. MARKET CLEARANCE
Glaxo Wellcome Inc. Receives Clearance to Market Amerge(TM) (Naratriptan Hydrochloride) Tablets in U.S.
KV Pharmaceutical Introduces New Nitroglycerin Sublingual Product.
First Horizon Pharmaceutical Corporation Announces FDA Approval of Smaller Nitrolingual(R) Pumpspray Bottle.
Nitroquick for chest pain.

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters